Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Servant

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
NPJ Precision Oncology|June 24, 2021
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trialIstvan Petak, Maud Kamal, Anna Dirner, et al.
The Journal of Pathology|May 17, 2021
SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic typeMamy Andrianteranagna, Joanna Cyrta, Julien Masliah-Planchon, et al.
British Journal of Cancer|November 16, 2020
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration siteMaud Kamal, Sonia Lameiras, Marc Deloger, et al.
British Journal of Cancer|April 13, 2023
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration siteMaud Kamal, Sonia Lameiras, Marc Deloger, et al.
Journal of Neurosurgery|April 8, 2023
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkersThibault Passeri, Tom Gutman, Abderaouf Hamza, et al.
Nature Communications|June 22, 2023
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trialManuel Rodrigues, Giulia Vanoni, Pierre Loap, et al.
Nature Communications|October 31, 2024
Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancerYohann Loriot, Maud Kamal, Laurene Syx, et al.
Nature Communications|October 4, 2024
The genomic and transcriptomic landscape of metastastic urothelial cancerYohann Loriot, Maud Kamal, Laurene Syx, et al.
BMC Biology|February 20, 2024
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routineCélia Dupain, Tom Gutman, Elodie Girard, et al.
Oral Oncology|November 29, 2024
Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNAGrégoire Marret, Constance Lamy, Sophie Vacher, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
NPJ Precision Oncology|June 24, 2021
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trialIstvan Petak, Maud Kamal, Anna Dirner, et al.
The Journal of Pathology|May 17, 2021
SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic typeMamy Andrianteranagna, Joanna Cyrta, Julien Masliah-Planchon, et al.
British Journal of Cancer|November 16, 2020
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration siteMaud Kamal, Sonia Lameiras, Marc Deloger, et al.
British Journal of Cancer|April 13, 2023
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration siteMaud Kamal, Sonia Lameiras, Marc Deloger, et al.
Journal of Neurosurgery|April 8, 2023
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkersThibault Passeri, Tom Gutman, Abderaouf Hamza, et al.
Nature Communications|June 22, 2023
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trialManuel Rodrigues, Giulia Vanoni, Pierre Loap, et al.
Nature Communications|October 31, 2024
Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancerYohann Loriot, Maud Kamal, Laurene Syx, et al.
Nature Communications|October 4, 2024
The genomic and transcriptomic landscape of metastastic urothelial cancerYohann Loriot, Maud Kamal, Laurene Syx, et al.
BMC Biology|February 20, 2024
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routineCélia Dupain, Tom Gutman, Elodie Girard, et al.
Oral Oncology|November 29, 2024
Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNAGrégoire Marret, Constance Lamy, Sophie Vacher, et al.
Pageof 13